Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients.

BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antiretroviral treatment are related to assay variation and/or increased sensitivity of new commercial assays. The 50-copy cut-off for virologic failure is, therefore, under debate. METHODS: Treated patient...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	PLoS ONE
المؤلفون الرئيسيون:	Laura Marije Hofstra, Tania Mudrikova, Arjen J Stam, Sigrid Otto, Kiki Tesselaar, Monique Nijhuis, Annemarie M J Wensing
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Public Library of Science (PLoS) 2014-01-01
الوصول للمادة أونلاين:	http://europepmc.org/articles/PMC4212971?pdf=render